We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Dual Microplate or Cuvette Spectrophotometer Increases Lab Flexibility

By LabMedica International staff writers
Posted on 14 Sep 2010
A state-of-the-art UV/visible spectrophotometer is now available that is suitable for both microplate and cuvette based measurements.

The new instrument is the BMG Labtech (Offenburg, Germany) SPECTROstar Nano. More...
The manufacturer describes it as an ultra-fast UV/visible absorbance spectrometer that can scan the entire spectrum from 220 nm to 1000 nm in less than one second per well with selectable spectral resolution of 1 nm to 10 nm. The instrument is compatible with all microplate formats from 6- to 1536-wells, and also has a standard cuvette port for individual samples.

The microplate format permits measurements of extremely low volumes (as little as two μL) for measurements of DNA, RNA, protein, etc. The instrument is capable of incubating both microplate and cuvette samples up to 45 °C with or without shaking. In addition, it is possible to flood the chamber with an inert gas in the event of atmospheric sensitive samples.

The SPECTROstar Nano is equipped with a new version of BMG Labtech's established reader control and comprehensive data analysis software, MARS. With a simple to use "Quick Run”' feature it reads ELISAs, RNA, DNA, protein (Bradford, BCA, and Lowry methods), cell growth, and beta-galactosidase assays using predefined protocols.

The speed of the spectrometer, its simple push button operation, and the ability to design and save individual assay protocols give users an unmatched flexibility to optimize settings for all absorbance experiments.

Related Links:
BMG Labtech


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Urine Drug Test
Instant-view® Phencyclidine Urine Drug Test
New
Varicella Zoster Test
ZEUS ELISA Varicella Zoster IgG Test System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: Switching to an experimental drug after liquid biopsy detection of breast cancer recurrence can improve outcomes (Photo courtesy of Shutterstock)

Treatment Switching Guided by Liquid Biopsy Blood Tests Improves Outcomes for Breast Cancer Patients

Standard treatment for patients with advanced estrogen receptor (ER)-positive, HER2-negative breast cancer, a subtype driven by estrogen receptors that fuel tumor growth, often involves aromatase inhibitors,... Read more

Pathology

view channel
Image: Microscopy image of invasive breast cancer cells degrading their underlying extracellular matrix (Photo courtesy of University of Turku)

Visualization Tool Illuminates Breast Cancer Cell Migration to Suggest New Treatment Avenues

Patients with breast cancer who progress from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) face a significantly worse prognosis, as metastatic disease remains incurable.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.